224 related articles for article (PubMed ID: 19240184)
21. Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.
Rosentraeger MJ; Garbrecht N; Anlauf M; Raffel A; Knoefel WT; Wiedenmann B; Klöppel G
Virchows Arch; 2016 Mar; 468(3):277-87. PubMed ID: 26649731
[TBL] [Abstract][Full Text] [Related]
22. Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan.
Kawamura J; Shimada Y; Komoto I; Okamoto H; Itami A; Doi R; Fujimoto K; Kosugi S; Imamura M
Oncol Rep; 2005 Jul; 14(1):47-52. PubMed ID: 15944766
[TBL] [Abstract][Full Text] [Related]
23. Location, incidence, and malignant potential of duodenal gastrinomas.
Thom AK; Norton JA; Axiotis CA; Jensen RT
Surgery; 1991 Dec; 110(6):1086-91; discussion 1091-3. PubMed ID: 1745977
[TBL] [Abstract][Full Text] [Related]
24. Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1.
Hackeng WM; van Beek DJ; Kok ASM; van Emst M; Morsink FHM; van Treijen MJC; Borel Rinkes IHM; Dreijerink KMA; Offerhaus GJA; Valk GD; Vriens MR; Brosens LAA
Am J Surg Pathol; 2022 Feb; 46(2):159-168. PubMed ID: 34560682
[TBL] [Abstract][Full Text] [Related]
25. Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1.
Gannon M; Gamer LW; Wright CV
Dev Biol; 2001 Oct; 238(1):185-201. PubMed ID: 11784003
[TBL] [Abstract][Full Text] [Related]
26. Sonic hedgehog and other soluble factors from differentiating embryoid bodies inhibit pancreas development.
Mfopou JK; De Groote V; Xu X; Heimberg H; Bouwens L
Stem Cells; 2007 May; 25(5):1156-65. PubMed ID: 17272496
[TBL] [Abstract][Full Text] [Related]
27. Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer.
Koizumi M; Doi R; Toyoda E; Masui T; Tulachan SS; Kawaguchi Y; Fujimoto K; Gittes GK; Imamura M
Surgery; 2003 Aug; 134(2):260-6. PubMed ID: 12947327
[TBL] [Abstract][Full Text] [Related]
28. Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas.
Serrano J; Goebel SU; Peghini PL; Lubensky IA; Gibril F; Jensen RT
J Clin Endocrinol Metab; 2000 Nov; 85(11):4146-56. PubMed ID: 11095446
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in the localization and surgical management of duodenal gastrinomas.
Lawton GP; Modlin IM
Curr Opin Gen Surg; 1994; ():131-7. PubMed ID: 7583948
[TBL] [Abstract][Full Text] [Related]
31. Duodenal microgastrinomas associated with Zollinger-Ellison syndrome.
Schröder W; Hölscher AH; Beckurts T; Richter TH; Höfler H; Siewert JR
Hepatogastroenterology; 1996; 43(12):1465-9. PubMed ID: 8975949
[TBL] [Abstract][Full Text] [Related]
32. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
33. Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness.
Goebel SU; Iwamoto M; Raffeld M; Gibril F; Hou W; Serrano J; Jensen RT
Cancer Res; 2002 Jul; 62(13):3702-10. PubMed ID: 12097278
[TBL] [Abstract][Full Text] [Related]
34. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
35. A rare surgical case of multiple liver resections for recurrent liver metastases from pancreatic gastrinoma: liver and vena cava resection.
Pachera S; Yokoyama Y; Nishio H; Oda K; Ebata T; Igami T; Abe T; Shingu Y; Nagino M
J Hepatobiliary Pancreat Surg; 2009; 16(5):692-8. PubMed ID: 19267257
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic-polypeptide cell hyperplasia associated with pancreatic or duodenal gastrinomas.
Martella EM; Ferraro G; Azzoni C; Marignani M; Bordi C
Hum Pathol; 1997 Feb; 28(2):149-53. PubMed ID: 9023394
[TBL] [Abstract][Full Text] [Related]
37. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
39. Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas.
Fendrich V; Langer P; Waldmann J; Bartsch DK; Rothmund M
Br J Surg; 2007 Nov; 94(11):1331-41. PubMed ID: 17939142
[TBL] [Abstract][Full Text] [Related]
40. The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells.
Lavon N; Yanuka O; Benvenisty N
Stem Cells; 2006 Aug; 24(8):1923-30. PubMed ID: 16675598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
